Biome Grow Inc.
Biome Grow Inc. BIO.CN Peers
See (BIO.CN) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BIO.CN | $0.01 | N/A | 562085.00 | -0.25 | -$0.02 | N/A |
| CURA.CN | $5.22 | +9.21% | 4.07B | -6.07 | -$0.86 | N/A |
| BHC.TO | $6.44 | +0.78% | 2.38B | -37.88 | -$0.17 | N/A |
| VRNO.CN | $6.32 | +6.76% | 2.17B | -5.40 | -$1.17 | N/A |
| GTII.CN | $7.94 | +2.85% | 1.89B | 27.38 | $0.29 | N/A |
| TRUL.CN | $6.49 | +3.18% | 1.27B | -5.90 | -$1.10 | N/A |
| CRON.TO | $2.91 | +1.04% | 1.12B | 14.55 | $0.20 | N/A |
| CURA.TO | $1.24 | +0.81% | 951.31M | -2.70 | -$0.46 | N/A |
| TER.CN | $2.38 | -0.42% | 804.79M | -1.33 | -$1.79 | N/A |
| DHT-UN.TO | $12.55 | +0.56% | 706.70M | -156.87 | -$0.08 | +7.75% |
Stock Comparison
BIO.CN vs CURA.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, CURA.CN has a market cap of 4.07B. Regarding current trading prices, BIO.CN is priced at $0.01, while CURA.CN trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, BIO.CN's ROE is -10.85%, compared to CURA.CN's ROE of -0.14%. Regarding short-term risk, BIO.CN is less volatile compared to CURA.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs BHC.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, BHC.TO has a market cap of 2.38B. Regarding current trading prices, BIO.CN is priced at $0.01, while BHC.TO trades at $6.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas BHC.TO's P/E ratio is -37.88. In terms of profitability, BIO.CN's ROE is -10.85%, compared to BHC.TO's ROE of +0.03%. Regarding short-term risk, BIO.CN is less volatile compared to BHC.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs VRNO.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, VRNO.CN has a market cap of 2.17B. Regarding current trading prices, BIO.CN is priced at $0.01, while VRNO.CN trades at $6.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas VRNO.CN's P/E ratio is -5.40. In terms of profitability, BIO.CN's ROE is -10.85%, compared to VRNO.CN's ROE of -0.10%. Regarding short-term risk, BIO.CN is less volatile compared to VRNO.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs GTII.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, GTII.CN has a market cap of 1.89B. Regarding current trading prices, BIO.CN is priced at $0.01, while GTII.CN trades at $7.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas GTII.CN's P/E ratio is 27.38. In terms of profitability, BIO.CN's ROE is -10.85%, compared to GTII.CN's ROE of +0.04%. Regarding short-term risk, BIO.CN is less volatile compared to GTII.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs TRUL.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, TRUL.CN has a market cap of 1.27B. Regarding current trading prices, BIO.CN is priced at $0.01, while TRUL.CN trades at $6.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas TRUL.CN's P/E ratio is -5.90. In terms of profitability, BIO.CN's ROE is -10.85%, compared to TRUL.CN's ROE of -0.12%. Regarding short-term risk, BIO.CN is less volatile compared to TRUL.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs CRON.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, CRON.TO has a market cap of 1.12B. Regarding current trading prices, BIO.CN is priced at $0.01, while CRON.TO trades at $2.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas CRON.TO's P/E ratio is 14.55. In terms of profitability, BIO.CN's ROE is -10.85%, compared to CRON.TO's ROE of +0.04%. Regarding short-term risk, BIO.CN is less volatile compared to CRON.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs CURA.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, CURA.TO has a market cap of 951.31M. Regarding current trading prices, BIO.CN is priced at $0.01, while CURA.TO trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas CURA.TO's P/E ratio is -2.70. In terms of profitability, BIO.CN's ROE is -10.85%, compared to CURA.TO's ROE of -0.22%. Regarding short-term risk, BIO.CN is less volatile compared to CURA.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs TER.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, TER.CN has a market cap of 804.79M. Regarding current trading prices, BIO.CN is priced at $0.01, while TER.CN trades at $2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas TER.CN's P/E ratio is -1.33. In terms of profitability, BIO.CN's ROE is -10.85%, compared to TER.CN's ROE of -0.37%. Regarding short-term risk, BIO.CN is less volatile compared to TER.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs DHT-UN.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, DHT-UN.TO has a market cap of 706.70M. Regarding current trading prices, BIO.CN is priced at $0.01, while DHT-UN.TO trades at $12.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas DHT-UN.TO's P/E ratio is -156.87. In terms of profitability, BIO.CN's ROE is -10.85%, compared to DHT-UN.TO's ROE of -0.01%. Regarding short-term risk, BIO.CN is less volatile compared to DHT-UN.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs TLRY.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, TLRY.TO has a market cap of 635.83M. Regarding current trading prices, BIO.CN is priced at $0.01, while TLRY.TO trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas TLRY.TO's P/E ratio is -0.42. In terms of profitability, BIO.CN's ROE is -10.85%, compared to TLRY.TO's ROE of -0.29%. Regarding short-term risk, BIO.CN is less volatile compared to TLRY.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs GUD.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, GUD.TO has a market cap of 580.78M. Regarding current trading prices, BIO.CN is priced at $0.01, while GUD.TO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas GUD.TO's P/E ratio is 58.40. In terms of profitability, BIO.CN's ROE is -10.85%, compared to GUD.TO's ROE of +0.01%. Regarding short-term risk, BIO.CN is less volatile compared to GUD.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs DHT-U.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, DHT-U.TO has a market cap of 464.56M. Regarding current trading prices, BIO.CN is priced at $0.01, while DHT-U.TO trades at $8.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas DHT-U.TO's P/E ratio is -137.50. In terms of profitability, BIO.CN's ROE is -10.85%, compared to DHT-U.TO's ROE of -0.01%. Regarding short-term risk, BIO.CN and DHT-U.TO have similar daily volatility (0.00).
BIO.CN vs VRNO.NE Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, VRNO.NE has a market cap of 388.50M. Regarding current trading prices, BIO.CN is priced at $0.01, while VRNO.NE trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas VRNO.NE's P/E ratio is -0.78. In terms of profitability, BIO.CN's ROE is -10.85%, compared to VRNO.NE's ROE of -0.27%. Regarding short-term risk, BIO.CN is less volatile compared to VRNO.NE. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs ACB.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, ACB.TO has a market cap of 379.25M. Regarding current trading prices, BIO.CN is priced at $0.01, while ACB.TO trades at $6.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas ACB.TO's P/E ratio is 25.59. In terms of profitability, BIO.CN's ROE is -10.85%, compared to ACB.TO's ROE of -0.06%. Regarding short-term risk, BIO.CN is less volatile compared to ACB.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs CL.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, CL.CN has a market cap of 340.59M. Regarding current trading prices, BIO.CN is priced at $0.01, while CL.CN trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas CL.CN's P/E ratio is -3.26. In terms of profitability, BIO.CN's ROE is -10.85%, compared to CL.CN's ROE of -0.16%. Regarding short-term risk, BIO.CN is less volatile compared to CL.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs WEED.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, WEED.TO has a market cap of 340.35M. Regarding current trading prices, BIO.CN is priced at $0.01, while WEED.TO trades at $1.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas WEED.TO's P/E ratio is -0.38. In terms of profitability, BIO.CN's ROE is -10.85%, compared to WEED.TO's ROE of -0.88%. Regarding short-term risk, BIO.CN is less volatile compared to WEED.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs CPH.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, CPH.TO has a market cap of 319.92M. Regarding current trading prices, BIO.CN is priced at $0.01, while CPH.TO trades at $12.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas CPH.TO's P/E ratio is 24.98. In terms of profitability, BIO.CN's ROE is -10.85%, compared to CPH.TO's ROE of +0.12%. Regarding short-term risk, BIO.CN is less volatile compared to CPH.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs CCHW.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, CCHW.CN has a market cap of 228.66M. Regarding current trading prices, BIO.CN is priced at $0.01, while CCHW.CN trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas CCHW.CN's P/E ratio is -0.41. In terms of profitability, BIO.CN's ROE is -10.85%, compared to CCHW.CN's ROE of -1.08%. Regarding short-term risk, BIO.CN and CCHW.CN have similar daily volatility (0.00).
BIO.CN vs OGI.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, OGI.TO has a market cap of 218.42M. Regarding current trading prices, BIO.CN is priced at $0.01, while OGI.TO trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas OGI.TO's P/E ratio is 9.61. In terms of profitability, BIO.CN's ROE is -10.85%, compared to OGI.TO's ROE of -0.18%. Regarding short-term risk, BIO.CN is less volatile compared to OGI.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs TSND.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, TSND.TO has a market cap of 172.87M. Regarding current trading prices, BIO.CN is priced at $0.01, while TSND.TO trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas TSND.TO's P/E ratio is 59.00. In terms of profitability, BIO.CN's ROE is -10.85%, compared to TSND.TO's ROE of -0.37%. Regarding short-term risk, BIO.CN is less volatile compared to TSND.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs TH.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, TH.TO has a market cap of 168.75M. Regarding current trading prices, BIO.CN is priced at $0.01, while TH.TO trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas TH.TO's P/E ratio is -36.70. In terms of profitability, BIO.CN's ROE is -10.85%, compared to TH.TO's ROE of +0.16%. Regarding short-term risk, BIO.CN is less volatile compared to TH.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs HLS.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, HLS.TO has a market cap of 149.75M. Regarding current trading prices, BIO.CN is priced at $0.01, while HLS.TO trades at $4.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas HLS.TO's P/E ratio is -5.89. In terms of profitability, BIO.CN's ROE is -10.85%, compared to HLS.TO's ROE of -0.24%. Regarding short-term risk, BIO.CN is less volatile compared to HLS.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs BHSC.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, BHSC.CN has a market cap of 137.76M. Regarding current trading prices, BIO.CN is priced at $0.01, while BHSC.CN trades at $7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas BHSC.CN's P/E ratio is -4.37. In terms of profitability, BIO.CN's ROE is -10.85%, compared to BHSC.CN's ROE of +9.56%. Regarding short-term risk, BIO.CN is less volatile compared to BHSC.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs GRIN.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, GRIN.CN has a market cap of 136.32M. Regarding current trading prices, BIO.CN is priced at $0.01, while GRIN.CN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas GRIN.CN's P/E ratio is -7.86. In terms of profitability, BIO.CN's ROE is -10.85%, compared to GRIN.CN's ROE of -0.89%. Regarding short-term risk, BIO.CN is less volatile compared to GRIN.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs CRDL.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, CRDL.TO has a market cap of 130.97M. Regarding current trading prices, BIO.CN is priced at $0.01, while CRDL.TO trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas CRDL.TO's P/E ratio is -3.11. In terms of profitability, BIO.CN's ROE is -10.85%, compared to CRDL.TO's ROE of -2.08%. Regarding short-term risk, BIO.CN is less volatile compared to CRDL.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs XLY.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, XLY.TO has a market cap of 124.74M. Regarding current trading prices, BIO.CN is priced at $0.01, while XLY.TO trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas XLY.TO's P/E ratio is -9.50. In terms of profitability, BIO.CN's ROE is -10.85%, compared to XLY.TO's ROE of -0.15%. Regarding short-term risk, BIO.CN is less volatile compared to XLY.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs PLTH.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, PLTH.CN has a market cap of 123.60M. Regarding current trading prices, BIO.CN is priced at $0.01, while PLTH.CN trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas PLTH.CN's P/E ratio is -1.73. In terms of profitability, BIO.CN's ROE is -10.85%, compared to PLTH.CN's ROE of -0.36%. Regarding short-term risk, BIO.CN is less volatile compared to PLTH.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs JUSH.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, JUSH.CN has a market cap of 93.43M. Regarding current trading prices, BIO.CN is priced at $0.01, while JUSH.CN trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas JUSH.CN's P/E ratio is -1.36. In terms of profitability, BIO.CN's ROE is -10.85%, compared to JUSH.CN's ROE of +1.45%. Regarding short-term risk, BIO.CN is less volatile compared to JUSH.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs GDNS.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, GDNS.CN has a market cap of 90.99M. Regarding current trading prices, BIO.CN is priced at $0.01, while GDNS.CN trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas GDNS.CN's P/E ratio is -2.74. In terms of profitability, BIO.CN's ROE is -10.85%, compared to GDNS.CN's ROE of +1.61%. Regarding short-term risk, BIO.CN and GDNS.CN have similar daily volatility (0.00).
BIO.CN vs MDP.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, MDP.TO has a market cap of 87.42M. Regarding current trading prices, BIO.CN is priced at $0.01, while MDP.TO trades at $2.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas MDP.TO's P/E ratio is 12.90. In terms of profitability, BIO.CN's ROE is -10.85%, compared to MDP.TO's ROE of +0.11%. Regarding short-term risk, BIO.CN is less volatile compared to MDP.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs TGOD.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, TGOD.CN has a market cap of 62.18M. Regarding current trading prices, BIO.CN is priced at $0.01, while TGOD.CN trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas TGOD.CN's P/E ratio is -3.28. In terms of profitability, BIO.CN's ROE is -10.85%, compared to TGOD.CN's ROE of -0.90%. Regarding short-term risk, BIO.CN and TGOD.CN have similar daily volatility (0.00).
BIO.CN vs BNXT.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, BNXT.CN has a market cap of 57.84M. Regarding current trading prices, BIO.CN is priced at $0.01, while BNXT.CN trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas BNXT.CN's P/E ratio is -7.29. In terms of profitability, BIO.CN's ROE is -10.85%, compared to BNXT.CN's ROE of +1.04%. Regarding short-term risk, BIO.CN and BNXT.CN have similar daily volatility (0.00).
BIO.CN vs STEM.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, STEM.CN has a market cap of 53.62M. Regarding current trading prices, BIO.CN is priced at $0.01, while STEM.CN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas STEM.CN's P/E ratio is -0.11. In terms of profitability, BIO.CN's ROE is -10.85%, compared to STEM.CN's ROE of -2.75%. Regarding short-term risk, BIO.CN and STEM.CN have similar daily volatility (0.00).
BIO.CN vs INNO.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, INNO.CN has a market cap of 47.87M. Regarding current trading prices, BIO.CN is priced at $0.01, while INNO.CN trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas INNO.CN's P/E ratio is -16.50. In terms of profitability, BIO.CN's ROE is -10.85%, compared to INNO.CN's ROE of -0.38%. Regarding short-term risk, BIO.CN is less volatile compared to INNO.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs MRMD.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, MRMD.CN has a market cap of 46.71M. Regarding current trading prices, BIO.CN is priced at $0.01, while MRMD.CN trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas MRMD.CN's P/E ratio is -3.00. In terms of profitability, BIO.CN's ROE is -10.85%, compared to MRMD.CN's ROE of -0.18%. Regarding short-term risk, BIO.CN is less volatile compared to MRMD.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs CBST.NE Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, CBST.NE has a market cap of 45.58M. Regarding current trading prices, BIO.CN is priced at $0.01, while CBST.NE trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas CBST.NE's P/E ratio is -0.31. In terms of profitability, BIO.CN's ROE is -10.85%, compared to CBST.NE's ROE of -6.64%. Regarding short-term risk, BIO.CN is less volatile compared to CBST.NE. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs AYR-A.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, AYR-A.CN has a market cap of 44.37M. Regarding current trading prices, BIO.CN is priced at $0.01, while AYR-A.CN trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas AYR-A.CN's P/E ratio is -0.08. In terms of profitability, BIO.CN's ROE is -10.85%, compared to AYR-A.CN's ROE of -0.68%. Regarding short-term risk, BIO.CN is less volatile compared to AYR-A.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs LABS.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, LABS.TO has a market cap of 39.44M. Regarding current trading prices, BIO.CN is priced at $0.01, while LABS.TO trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas LABS.TO's P/E ratio is -3.17. In terms of profitability, BIO.CN's ROE is -10.85%, compared to LABS.TO's ROE of -0.23%. Regarding short-term risk, BIO.CN is less volatile compared to LABS.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs HEXO.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, HEXO.TO has a market cap of 38.72M. Regarding current trading prices, BIO.CN is priced at $0.01, while HEXO.TO trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas HEXO.TO's P/E ratio is -0.26. In terms of profitability, BIO.CN's ROE is -10.85%, compared to HEXO.TO's ROE of -2.06%. Regarding short-term risk, BIO.CN is less volatile compared to HEXO.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs CHM.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, CHM.CN has a market cap of 37.21M. Regarding current trading prices, BIO.CN is priced at $0.01, while CHM.CN trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas CHM.CN's P/E ratio is -5.00. In terms of profitability, BIO.CN's ROE is -10.85%, compared to CHM.CN's ROE of +0.15%. Regarding short-term risk, BIO.CN and CHM.CN have similar daily volatility (0.00).
BIO.CN vs IAN.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, IAN.CN has a market cap of 33.68M. Regarding current trading prices, BIO.CN is priced at $0.01, while IAN.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas IAN.CN's P/E ratio is -0.50. In terms of profitability, BIO.CN's ROE is -10.85%, compared to IAN.CN's ROE of +0.10%. Regarding short-term risk, BIO.CN and IAN.CN have similar daily volatility (0.00).
BIO.CN vs AVCN.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, AVCN.TO has a market cap of 31.88M. Regarding current trading prices, BIO.CN is priced at $0.01, while AVCN.TO trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas AVCN.TO's P/E ratio is -7.12. In terms of profitability, BIO.CN's ROE is -10.85%, compared to AVCN.TO's ROE of -3.82%. Regarding short-term risk, BIO.CN is less volatile compared to AVCN.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs EPIC.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, EPIC.CN has a market cap of 29.43M. Regarding current trading prices, BIO.CN is priced at $0.01, while EPIC.CN trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas EPIC.CN's P/E ratio is 12.50. In terms of profitability, BIO.CN's ROE is -10.85%, compared to EPIC.CN's ROE of +0.06%. Regarding short-term risk, BIO.CN and EPIC.CN have similar daily volatility (0.00).
BIO.CN vs MMEN.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, MMEN.CN has a market cap of 27.66M. Regarding current trading prices, BIO.CN is priced at $0.01, while MMEN.CN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas MMEN.CN's P/E ratio is -0.13. In terms of profitability, BIO.CN's ROE is -10.85%, compared to MMEN.CN's ROE of -0.96%. Regarding short-term risk, BIO.CN is less volatile compared to MMEN.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs VEXT.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, VEXT.CN has a market cap of 27.23M. Regarding current trading prices, BIO.CN is priced at $0.01, while VEXT.CN trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas VEXT.CN's P/E ratio is -1.00. In terms of profitability, BIO.CN's ROE is -10.85%, compared to VEXT.CN's ROE of -0.27%. Regarding short-term risk, BIO.CN is less volatile compared to VEXT.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs GWAY.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, GWAY.CN has a market cap of 24.99M. Regarding current trading prices, BIO.CN is priced at $0.01, while GWAY.CN trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas GWAY.CN's P/E ratio is -6.33. In terms of profitability, BIO.CN's ROE is -10.85%, compared to GWAY.CN's ROE of -0.33%. Regarding short-term risk, BIO.CN and GWAY.CN have similar daily volatility (0.00).
BIO.CN vs CXXI.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, CXXI.CN has a market cap of 24.01M. Regarding current trading prices, BIO.CN is priced at $0.01, while CXXI.CN trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas CXXI.CN's P/E ratio is -5.00. In terms of profitability, BIO.CN's ROE is -10.85%, compared to CXXI.CN's ROE of -0.14%. Regarding short-term risk, BIO.CN and CXXI.CN have similar daily volatility (0.00).
BIO.CN vs CWEB.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, CWEB.TO has a market cap of 23.79M. Regarding current trading prices, BIO.CN is priced at $0.01, while CWEB.TO trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas CWEB.TO's P/E ratio is -0.56. In terms of profitability, BIO.CN's ROE is -10.85%, compared to CWEB.TO's ROE of -0.85%. Regarding short-term risk, BIO.CN is less volatile compared to CWEB.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs YOUR.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, YOUR.CN has a market cap of 22.94M. Regarding current trading prices, BIO.CN is priced at $0.01, while YOUR.CN trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas YOUR.CN's P/E ratio is 8.50. In terms of profitability, BIO.CN's ROE is -10.85%, compared to YOUR.CN's ROE of -1.18%. Regarding short-term risk, BIO.CN and YOUR.CN have similar daily volatility (0.00).
BIO.CN vs VIN.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, VIN.CN has a market cap of 20.18M. Regarding current trading prices, BIO.CN is priced at $0.01, while VIN.CN trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas VIN.CN's P/E ratio is -0.67. In terms of profitability, BIO.CN's ROE is -10.85%, compared to VIN.CN's ROE of -3.88%. Regarding short-term risk, Volatility data is not available for a full comparison. BIO.CN has daily volatility of 0.00 and VIN.CN has daily volatility of N/A.
BIO.CN vs RWB.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, RWB.CN has a market cap of 18.81M. Regarding current trading prices, BIO.CN is priced at $0.01, while RWB.CN trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas RWB.CN's P/E ratio is -0.15. In terms of profitability, BIO.CN's ROE is -10.85%, compared to RWB.CN's ROE of +0.87%. Regarding short-term risk, BIO.CN and RWB.CN have similar daily volatility (0.00).
BIO.CN vs MRV.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, MRV.TO has a market cap of 15.37M. Regarding current trading prices, BIO.CN is priced at $0.01, while MRV.TO trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas MRV.TO's P/E ratio is -19.29. In terms of profitability, BIO.CN's ROE is -10.85%, compared to MRV.TO's ROE of N/A. Regarding short-term risk, BIO.CN is less volatile compared to MRV.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs EXM.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, EXM.CN has a market cap of 15.15M. Regarding current trading prices, BIO.CN is priced at $0.01, while EXM.CN trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas EXM.CN's P/E ratio is -0.91. In terms of profitability, BIO.CN's ROE is -10.85%, compared to EXM.CN's ROE of -18.63%. Regarding short-term risk, BIO.CN and EXM.CN have similar daily volatility (0.00).
BIO.CN vs CHAL.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, CHAL.CN has a market cap of 14.70M. Regarding current trading prices, BIO.CN is priced at $0.01, while CHAL.CN trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas CHAL.CN's P/E ratio is -2.25. In terms of profitability, BIO.CN's ROE is -10.85%, compared to CHAL.CN's ROE of +0.00%. Regarding short-term risk, BIO.CN and CHAL.CN have similar daily volatility (0.00).
BIO.CN vs RIV.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, RIV.CN has a market cap of 13.70M. Regarding current trading prices, BIO.CN is priced at $0.01, while RIV.CN trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas RIV.CN's P/E ratio is -0.21. In terms of profitability, BIO.CN's ROE is -10.85%, compared to RIV.CN's ROE of -0.92%. Regarding short-term risk, BIO.CN and RIV.CN have similar daily volatility (0.00).
BIO.CN vs TRIP.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, TRIP.CN has a market cap of 12.03M. Regarding current trading prices, BIO.CN is priced at $0.01, while TRIP.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas TRIP.CN's P/E ratio is -1.50. In terms of profitability, BIO.CN's ROE is -10.85%, compared to TRIP.CN's ROE of -0.33%. Regarding short-term risk, BIO.CN is less volatile compared to TRIP.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs ORI.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, ORI.CN has a market cap of 11.72M. Regarding current trading prices, BIO.CN is priced at $0.01, while ORI.CN trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas ORI.CN's P/E ratio is -2.11. In terms of profitability, BIO.CN's ROE is -10.85%, compared to ORI.CN's ROE of +0.51%. Regarding short-term risk, BIO.CN and ORI.CN have similar daily volatility (0.00).
BIO.CN vs PWR.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, PWR.CN has a market cap of 11.70M. Regarding current trading prices, BIO.CN is priced at $0.01, while PWR.CN trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas PWR.CN's P/E ratio is -1.33. In terms of profitability, BIO.CN's ROE is -10.85%, compared to PWR.CN's ROE of -0.79%. Regarding short-term risk, BIO.CN and PWR.CN have similar daily volatility (0.00).
BIO.CN vs CLC.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, CLC.CN has a market cap of 11.27M. Regarding current trading prices, BIO.CN is priced at $0.01, while CLC.CN trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas CLC.CN's P/E ratio is 5.00. In terms of profitability, BIO.CN's ROE is -10.85%, compared to CLC.CN's ROE of +0.11%. Regarding short-term risk, BIO.CN and CLC.CN have similar daily volatility (0.00).
BIO.CN vs RVV.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, RVV.CN has a market cap of 10.46M. Regarding current trading prices, BIO.CN is priced at $0.01, while RVV.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas RVV.CN's P/E ratio is -2.50. In terms of profitability, BIO.CN's ROE is -10.85%, compared to RVV.CN's ROE of -0.70%. Regarding short-term risk, BIO.CN and RVV.CN have similar daily volatility (0.00).
BIO.CN vs AVNT.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, AVNT.TO has a market cap of 10.17M. Regarding current trading prices, BIO.CN is priced at $0.01, while AVNT.TO trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas AVNT.TO's P/E ratio is -0.45. In terms of profitability, BIO.CN's ROE is -10.85%, compared to AVNT.TO's ROE of -0.53%. Regarding short-term risk, BIO.CN is less volatile compared to AVNT.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs CNFA.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, CNFA.CN has a market cap of 9.78M. Regarding current trading prices, BIO.CN is priced at $0.01, while CNFA.CN trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas CNFA.CN's P/E ratio is -0.83. In terms of profitability, BIO.CN's ROE is -10.85%, compared to CNFA.CN's ROE of -7.84%. Regarding short-term risk, BIO.CN and CNFA.CN have similar daily volatility (0.00).
BIO.CN vs CTX.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, CTX.TO has a market cap of 9.69M. Regarding current trading prices, BIO.CN is priced at $0.01, while CTX.TO trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas CTX.TO's P/E ratio is -3.64. In terms of profitability, BIO.CN's ROE is -10.85%, compared to CTX.TO's ROE of -0.16%. Regarding short-term risk, BIO.CN is less volatile compared to CTX.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs VIVO.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, VIVO.TO has a market cap of 9.27M. Regarding current trading prices, BIO.CN is priced at $0.01, while VIVO.TO trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas VIVO.TO's P/E ratio is -0.16. In terms of profitability, BIO.CN's ROE is -10.85%, compared to VIVO.TO's ROE of -0.78%. Regarding short-term risk, BIO.CN is less volatile compared to VIVO.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs AUSA.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, AUSA.CN has a market cap of 9.16M. Regarding current trading prices, BIO.CN is priced at $0.01, while AUSA.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas AUSA.CN's P/E ratio is -0.11. In terms of profitability, BIO.CN's ROE is -10.85%, compared to AUSA.CN's ROE of +0.00%. Regarding short-term risk, BIO.CN and AUSA.CN have similar daily volatility (0.00).
BIO.CN vs OILS.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, OILS.CN has a market cap of 9.15M. Regarding current trading prices, BIO.CN is priced at $0.01, while OILS.CN trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas OILS.CN's P/E ratio is -5.50. In terms of profitability, BIO.CN's ROE is -10.85%, compared to OILS.CN's ROE of -0.22%. Regarding short-term risk, BIO.CN is less volatile compared to OILS.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs MVMD.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, MVMD.CN has a market cap of 8.81M. Regarding current trading prices, BIO.CN is priced at $0.01, while MVMD.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas MVMD.CN's P/E ratio is -2.50. In terms of profitability, BIO.CN's ROE is -10.85%, compared to MVMD.CN's ROE of -0.47%. Regarding short-term risk, BIO.CN and MVMD.CN have similar daily volatility (0.00).
BIO.CN vs AH.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, AH.TO has a market cap of 8.07M. Regarding current trading prices, BIO.CN is priced at $0.01, while AH.TO trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas AH.TO's P/E ratio is -0.22. In terms of profitability, BIO.CN's ROE is -10.85%, compared to AH.TO's ROE of -0.58%. Regarding short-term risk, BIO.CN is less volatile compared to AH.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs STHZ.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, STHZ.CN has a market cap of 7.69M. Regarding current trading prices, BIO.CN is priced at $0.01, while STHZ.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas STHZ.CN's P/E ratio is -0.10. In terms of profitability, BIO.CN's ROE is -10.85%, compared to STHZ.CN's ROE of +0.10%. Regarding short-term risk, BIO.CN and STHZ.CN have similar daily volatility (0.00).
BIO.CN vs MOJO.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, MOJO.CN has a market cap of 7.46M. Regarding current trading prices, BIO.CN is priced at $0.01, while MOJO.CN trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas MOJO.CN's P/E ratio is -5.36. In terms of profitability, BIO.CN's ROE is -10.85%, compared to MOJO.CN's ROE of -11.49%. Regarding short-term risk, BIO.CN and MOJO.CN have similar daily volatility (0.00).
BIO.CN vs SPR.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, SPR.CN has a market cap of 7.29M. Regarding current trading prices, BIO.CN is priced at $0.01, while SPR.CN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas SPR.CN's P/E ratio is -0.40. In terms of profitability, BIO.CN's ROE is -10.85%, compared to SPR.CN's ROE of +0.00%. Regarding short-term risk, BIO.CN and SPR.CN have similar daily volatility (0.00).
BIO.CN vs CLSH.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, CLSH.CN has a market cap of 7.14M. Regarding current trading prices, BIO.CN is priced at $0.01, while CLSH.CN trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas CLSH.CN's P/E ratio is 4.00. In terms of profitability, BIO.CN's ROE is -10.85%, compared to CLSH.CN's ROE of -0.04%. Regarding short-term risk, BIO.CN and CLSH.CN have similar daily volatility (0.00).
BIO.CN vs CDVA.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, CDVA.CN has a market cap of 7.14M. Regarding current trading prices, BIO.CN is priced at $0.01, while CDVA.CN trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas CDVA.CN's P/E ratio is -6.50. In terms of profitability, BIO.CN's ROE is -10.85%, compared to CDVA.CN's ROE of +0.26%. Regarding short-term risk, BIO.CN and CDVA.CN have similar daily volatility (0.00).
BIO.CN vs IMCC.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, IMCC.CN has a market cap of 7.00M. Regarding current trading prices, BIO.CN is priced at $0.01, while IMCC.CN trades at $2.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas IMCC.CN's P/E ratio is -0.50. In terms of profitability, BIO.CN's ROE is -10.85%, compared to IMCC.CN's ROE of -1.52%. Regarding short-term risk, BIO.CN and IMCC.CN have similar daily volatility (0.00).
BIO.CN vs MYCO.NE Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, MYCO.NE has a market cap of 6.33M. Regarding current trading prices, BIO.CN is priced at $0.01, while MYCO.NE trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas MYCO.NE's P/E ratio is -0.22. In terms of profitability, BIO.CN's ROE is -10.85%, compared to MYCO.NE's ROE of +0.94%. Regarding short-term risk, BIO.CN is less volatile compared to MYCO.NE. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs SNN.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, SNN.CN has a market cap of 6.08M. Regarding current trading prices, BIO.CN is priced at $0.01, while SNN.CN trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas SNN.CN's P/E ratio is -0.15. In terms of profitability, BIO.CN's ROE is -10.85%, compared to SNN.CN's ROE of +0.00%. Regarding short-term risk, BIO.CN and SNN.CN have similar daily volatility (0.00).
BIO.CN vs SE.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, SE.CN has a market cap of 5.81M. Regarding current trading prices, BIO.CN is priced at $0.01, while SE.CN trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas SE.CN's P/E ratio is 2.14. In terms of profitability, BIO.CN's ROE is -10.85%, compared to SE.CN's ROE of -0.71%. Regarding short-term risk, BIO.CN is less volatile compared to SE.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs FH.NE Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, FH.NE has a market cap of 5.24M. Regarding current trading prices, BIO.CN is priced at $0.01, while FH.NE trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas FH.NE's P/E ratio is -1.00. In terms of profitability, BIO.CN's ROE is -10.85%, compared to FH.NE's ROE of -2.14%. Regarding short-term risk, BIO.CN and FH.NE have similar daily volatility (0.00).
BIO.CN vs WLLW.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, WLLW.TO has a market cap of 5.07M. Regarding current trading prices, BIO.CN is priced at $0.01, while WLLW.TO trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas WLLW.TO's P/E ratio is -0.70. In terms of profitability, BIO.CN's ROE is -10.85%, compared to WLLW.TO's ROE of -21.00%. Regarding short-term risk, BIO.CN is less volatile compared to WLLW.TO. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs BCBC.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, BCBC.CN has a market cap of 5.02M. Regarding current trading prices, BIO.CN is priced at $0.01, while BCBC.CN trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas BCBC.CN's P/E ratio is -2.00. In terms of profitability, BIO.CN's ROE is -10.85%, compared to BCBC.CN's ROE of -4.27%. Regarding short-term risk, BIO.CN is less volatile compared to BCBC.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs AYUR.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, AYUR.CN has a market cap of 4.87M. Regarding current trading prices, BIO.CN is priced at $0.01, while AYUR.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas AYUR.CN's P/E ratio is -1.25. In terms of profitability, BIO.CN's ROE is -10.85%, compared to AYUR.CN's ROE of -3.52%. Regarding short-term risk, BIO.CN and AYUR.CN have similar daily volatility (0.00).
BIO.CN vs AION.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, AION.CN has a market cap of 4.84M. Regarding current trading prices, BIO.CN is priced at $0.01, while AION.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas AION.CN's P/E ratio is -0.50. In terms of profitability, BIO.CN's ROE is -10.85%, compared to AION.CN's ROE of +1.59%. Regarding short-term risk, BIO.CN and AION.CN have similar daily volatility (0.00).
BIO.CN vs CANN.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, CANN.CN has a market cap of 4.72M. Regarding current trading prices, BIO.CN is priced at $0.01, while CANN.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas CANN.CN's P/E ratio is -0.25. In terms of profitability, BIO.CN's ROE is -10.85%, compared to CANN.CN's ROE of -0.66%. Regarding short-term risk, BIO.CN and CANN.CN have similar daily volatility (0.00).
BIO.CN vs BHNG.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, BHNG.CN has a market cap of 4.70M. Regarding current trading prices, BIO.CN is priced at $0.01, while BHNG.CN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas BHNG.CN's P/E ratio is -1.00. In terms of profitability, BIO.CN's ROE is -10.85%, compared to BHNG.CN's ROE of +4.01%. Regarding short-term risk, BIO.CN and BHNG.CN have similar daily volatility (0.00).
BIO.CN vs LOBE.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, LOBE.CN has a market cap of 4.58M. Regarding current trading prices, BIO.CN is priced at $0.01, while LOBE.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas LOBE.CN's P/E ratio is -0.62. In terms of profitability, BIO.CN's ROE is -10.85%, compared to LOBE.CN's ROE of +1.67%. Regarding short-term risk, BIO.CN is less volatile compared to LOBE.CN. This indicates potentially lower risk in terms of short-term price fluctuations for BIO.CN.
BIO.CN vs FFNT.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, FFNT.CN has a market cap of 4.57M. Regarding current trading prices, BIO.CN is priced at $0.01, while FFNT.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas FFNT.CN's P/E ratio is -0.03. In terms of profitability, BIO.CN's ROE is -10.85%, compared to FFNT.CN's ROE of +0.79%. Regarding short-term risk, BIO.CN and FFNT.CN have similar daily volatility (0.00).
BIO.CN vs LUFF.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, LUFF.CN has a market cap of 4.02M. Regarding current trading prices, BIO.CN is priced at $0.01, while LUFF.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas LUFF.CN's P/E ratio is -0.56. In terms of profitability, BIO.CN's ROE is -10.85%, compared to LUFF.CN's ROE of -0.32%. Regarding short-term risk, Volatility data is not available for a full comparison. BIO.CN has daily volatility of 0.00 and LUFF.CN has daily volatility of N/A.
BIO.CN vs TILT.NE Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, TILT.NE has a market cap of 3.91M. Regarding current trading prices, BIO.CN is priced at $0.01, while TILT.NE trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas TILT.NE's P/E ratio is -0.03. In terms of profitability, BIO.CN's ROE is -10.85%, compared to TILT.NE's ROE of -10.80%. Regarding short-term risk, BIO.CN and TILT.NE have similar daily volatility (0.00).
BIO.CN vs BAMM.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, BAMM.CN has a market cap of 3.69M. Regarding current trading prices, BIO.CN is priced at $0.01, while BAMM.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas BAMM.CN's P/E ratio is -0.12. In terms of profitability, BIO.CN's ROE is -10.85%, compared to BAMM.CN's ROE of +0.24%. Regarding short-term risk, BIO.CN and BAMM.CN have similar daily volatility (0.00).
BIO.CN vs RMC.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, RMC.CN has a market cap of 3.44M. Regarding current trading prices, BIO.CN is priced at $0.01, while RMC.CN trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas RMC.CN's P/E ratio is -4.00. In terms of profitability, BIO.CN's ROE is -10.85%, compared to RMC.CN's ROE of +8.03%. Regarding short-term risk, BIO.CN and RMC.CN have similar daily volatility (0.00).
BIO.CN vs XBRA.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, XBRA.CN has a market cap of 3.38M. Regarding current trading prices, BIO.CN is priced at $0.01, while XBRA.CN trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas XBRA.CN's P/E ratio is -1.50. In terms of profitability, BIO.CN's ROE is -10.85%, compared to XBRA.CN's ROE of -20.92%. Regarding short-term risk, BIO.CN and XBRA.CN have similar daily volatility (0.00).
BIO.CN vs THC.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, THC.CN has a market cap of 3.28M. Regarding current trading prices, BIO.CN is priced at $0.01, while THC.CN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas THC.CN's P/E ratio is -1.00. In terms of profitability, BIO.CN's ROE is -10.85%, compared to THC.CN's ROE of +0.00%. Regarding short-term risk, BIO.CN and THC.CN have similar daily volatility (0.00).
BIO.CN vs NBUD.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, NBUD.CN has a market cap of 3.17M. Regarding current trading prices, BIO.CN is priced at $0.01, while NBUD.CN trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas NBUD.CN's P/E ratio is -1.25. In terms of profitability, BIO.CN's ROE is -10.85%, compared to NBUD.CN's ROE of -0.54%. Regarding short-term risk, BIO.CN and NBUD.CN have similar daily volatility (0.00).
BIO.CN vs MSVN.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, MSVN.CN has a market cap of 2.92M. Regarding current trading prices, BIO.CN is priced at $0.01, while MSVN.CN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas MSVN.CN's P/E ratio is -0.06. In terms of profitability, BIO.CN's ROE is -10.85%, compared to MSVN.CN's ROE of +19.42%. Regarding short-term risk, BIO.CN and MSVN.CN have similar daily volatility (0.00).
BIO.CN vs AREV.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, AREV.CN has a market cap of 2.86M. Regarding current trading prices, BIO.CN is priced at $0.01, while AREV.CN trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas AREV.CN's P/E ratio is -2.25. In terms of profitability, BIO.CN's ROE is -10.85%, compared to AREV.CN's ROE of +2.76%. Regarding short-term risk, BIO.CN and AREV.CN have similar daily volatility (0.00).
BIO.CN vs ASP.TO Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, ASP.TO has a market cap of 2.77M. Regarding current trading prices, BIO.CN is priced at $0.01, while ASP.TO trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas ASP.TO's P/E ratio is -0.08. In terms of profitability, BIO.CN's ROE is -10.85%, compared to ASP.TO's ROE of +3.10%. Regarding short-term risk, BIO.CN and ASP.TO have similar daily volatility (0.00).
BIO.CN vs CFT.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, CFT.CN has a market cap of 2.65M. Regarding current trading prices, BIO.CN is priced at $0.01, while CFT.CN trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas CFT.CN's P/E ratio is -0.13. In terms of profitability, BIO.CN's ROE is -10.85%, compared to CFT.CN's ROE of +0.00%. Regarding short-term risk, BIO.CN and CFT.CN have similar daily volatility (0.00).
BIO.CN vs IPOT.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, IPOT.CN has a market cap of 2.64M. Regarding current trading prices, BIO.CN is priced at $0.01, while IPOT.CN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas IPOT.CN's P/E ratio is -0.50. In terms of profitability, BIO.CN's ROE is -10.85%, compared to IPOT.CN's ROE of +0.00%. Regarding short-term risk, BIO.CN and IPOT.CN have similar daily volatility (0.00).
BIO.CN vs PBF.CN Comparison
BIO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIO.CN stands at 562085.00. In comparison, PBF.CN has a market cap of 2.61M. Regarding current trading prices, BIO.CN is priced at $0.01, while PBF.CN trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIO.CN currently has a P/E ratio of -0.25, whereas PBF.CN's P/E ratio is -0.37. In terms of profitability, BIO.CN's ROE is -10.85%, compared to PBF.CN's ROE of +1.52%. Regarding short-term risk, BIO.CN and PBF.CN have similar daily volatility (0.00).